603718 *ST海利
已收盘 05-15 15:00:00
资讯
新帖
简况
每周股票复盘：*ST海利（603718）控股子公司完成七家口腔公司并购
证券之星 · 04:28
每周股票复盘：*ST海利（603718）控股子公司完成七家口腔公司并购
*ST海利（603718）披露控股子公司收购口腔连锁公司股权进展公告，5月14日股价下跌2.05%
证券之星 · 05-14
*ST海利（603718）披露控股子公司收购口腔连锁公司股权进展公告，5月14日股价下跌2.05%
股市必读：*ST海利（603718）今年截至5月7日累计跌幅已超40%
证券之星 · 05-08
股市必读：*ST海利（603718）今年截至5月7日累计跌幅已超40%
每周股票复盘：海利生物（603718）将被实施退市风险警示
证券之星 · 05-02
每周股票复盘：海利生物（603718）将被实施退市风险警示
海利生物(603718)3月31日股东户数4.09万户，较上期增加7.27%
证券之星 · 04-30
海利生物(603718)3月31日股东户数4.09万户，较上期增加7.27%
图解海利生物一季报：第一季度单季净利润同比下降41.88%
证券之星 · 04-30
图解海利生物一季报：第一季度单季净利润同比下降41.88%
海利生物最新公告：5月6日起实施退市风险警示股票简称变更为“*ST海利”
证券之星 · 04-29
海利生物最新公告：5月6日起实施退市风险警示股票简称变更为“*ST海利”
海利生物将于4月30日停牌一天 实施退市风险警示
美股速递 · 04-29
海利生物将于4月30日停牌一天 实施退市风险警示
股市必读：海利生物（603718）预计2025年全年营业收入1.88亿元
证券之星 · 04-27
股市必读：海利生物（603718）预计2025年全年营业收入1.88亿元
每周股票复盘：海利生物（603718）预计2025年营收约1.88亿元
证券之星 · 04-26
每周股票复盘：海利生物（603718）预计2025年营收约1.88亿元
603359、603718，业绩预告有变，均面临被“*ST”风险
每日经济新闻 · 04-24
603359、603718，业绩预告有变，均面临被“*ST”风险
海利生物最新公告：预计2025年净亏损3.14亿元左右
证券之星 · 04-24
海利生物最新公告：预计2025年净亏损3.14亿元左右
股市必读：海利生物（603718）4月17日收盘跌5.07%，今年累计跌幅已超20%
证券之星 · 04-20
股市必读：海利生物（603718）4月17日收盘跌5.07%，今年累计跌幅已超20%
每周股票复盘：海利生物（603718）调整瑞盛生物收购价款支付
证券之星 · 04-19
每周股票复盘：海利生物（603718）调整瑞盛生物收购价款支付
海利生物（603718）披露调整控股子公司收购常州两家口腔连锁公司股权相关价款支付安排的公告，4月16日股价上涨1.11%
证券之星 · 04-16
海利生物（603718）披露调整控股子公司收购常州两家口腔连锁公司股权相关价款支付安排的公告，4月16日股价上涨1.11%
海利生物(603718.SH)拟投资设立二级子公司并受让扬州、常州七家口腔连锁公司股权
智通财经 · 04-15
海利生物(603718.SH)拟投资设立二级子公司并受让扬州、常州七家口腔连锁公司股权
每周股票复盘：海利生物（603718）控股子公司收购七家口腔公司股权
证券之星 · 04-12
每周股票复盘：海利生物（603718）控股子公司收购七家口腔公司股权
海利生物（603718）披露控股子公司收购口腔连锁公司股权进展公告，4月7日股价上涨3.39%
证券之星 · 04-07
海利生物（603718）披露控股子公司收购口腔连锁公司股权进展公告，4月7日股价上涨3.39%
海利生物(603718.SH)：瑞盛生物的GORORISE可吸收胶原膜产品获得MOH批准
智通财经网 · 04-07
海利生物(603718.SH)：瑞盛生物的GORORISE可吸收胶原膜产品获得MOH批准
每周股票复盘：海利生物（603718）瑞盛生物拟收购七家口腔公司股权
证券之星 · 04-05
每周股票复盘：海利生物（603718）瑞盛生物拟收购七家口腔公司股权
暂无数据
公司概况
公司名称：
上海海利生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2015-05-15
主营业务：
上海海利生物技术股份有限公司的主营业务是体外诊断试剂（IVD）业务板块和口腔组织修复与再生材料业务板块。公司的主要产品是体外诊断试剂、口腔组织修复与再生材料。公司子公司捷门生物被认定为“上海市专精特新中小企业”、“上海市科技小巨人培育企业”，控股子公司瑞盛生物是陕西省瞪羚企业、陕西省“专精特新”中小企业和陕西省工业企业研发机构。
发行价格：
6.81
{"stockData":{"symbol":"603718","market":"SH","secType":"STK","nameCN":"*ST海利","latestPrice":3.88,"timestamp":1778828400000,"preClose":3.83,"halted":0,"volume":14851465,"delay":0,"changeRate":0.0131,"floatShares":649000000,"shares":652000000,"eps":-0.4848,"marketStatus":"已收盘","change":0.05,"latestTime":"05-15 15:00:00","open":3.8,"high":3.98,"low":3.77,"amount":57932100,"amplitude":0.0548,"askPrice":3.88,"askSize":2582,"bidPrice":3.87,"bidSize":1006,"shortable":0,"etf":0,"ttmEps":-0.4848,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":3.83,"symbolType":"stock","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":4.02,"lowLimit":3.64,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":651904700,"isCdr":false,"pbRate":2.85,"roa":"--","roe":"0.716%","epsLYR":-0.48,"committee":0.148233,"marketValue":2529000000,"turnoverRate":0.0229,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-05-18。","floatMarketCap":2518000000},"requestUrl":"/m/hq/s/603718/tweets","defaultTab":"tweets","newsList":[{"id":"2636626240","title":"每周股票复盘：*ST海利（603718）控股子公司完成七家口腔公司并购","url":"https://stock-news.laohu8.com/highlight/detail?id=2636626240","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636626240?lang=zh_cn&edition=full","pubTime":"2026-05-17 04:28","pubTimestamp":1778963291,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，*ST海利报收于3.88元，较上周的3.66元上涨6.01%。本周，*ST海利5月13日盘中最高价报4.03元。本周关注点公司公告汇总：控股子公司瑞盛生物以6,120万元收购七家口腔连锁公司各51%股权并完成工商变更。截至2026年5月14日，七家公司已完成股权转让的工商变更登记手续，其中溧阳金铂利口腔门诊部有限公司和溧阳溧城金铂利口腔门诊部有限公司已领取新营业执照。股权结构均为瑞盛生物持股51%，邹春洋持股44%，谢守良持股5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","603718","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635871657","title":"*ST海利（603718）披露控股子公司收购口腔连锁公司股权进展公告，5月14日股价下跌2.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635871657","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635871657?lang=zh_cn&edition=full","pubTime":"2026-05-14 18:29","pubTimestamp":1778754554,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，*ST海利报收于3.83元，较前一交易日下跌2.05%，最新总市值为24.97亿元。公司于近日披露《关于控股子公司收购口腔连锁公司股权的进展公告》。公告显示，上海海利生物技术股份有限公司控股子公司陕西瑞盛生物科技有限公司以自有资金收购扬州、常州七家口腔连锁公司各51%股权，交易总额6,120万元。股权结构均为瑞盛生物持股51%，邹春洋持股44%，谢守良持股5%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400035110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0239","BK0070","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633493127","title":"股市必读：*ST海利（603718）今年截至5月7日累计跌幅已超40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633493127","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633493127?lang=zh_cn&edition=full","pubTime":"2026-05-08 01:38","pubTimestamp":1778175492,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，*ST海利报收于3.53元，下跌4.85%，换手率8.82%，成交量57.21万手，成交额2.02亿元。交易信息汇总股价提醒5月7日*ST海利收盘报3.53元，跌4.85%，当日成交5721.1万元。该股已连续2日下跌，当年累计跌幅40.3%。前10个交易日资金流向显示：主力资金累计净流入712.45万元，股价累计下跌13.69%；融资余额累计减少1545.34万元，融券余量累计减少300股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800001652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0046","603718","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632626920","title":"每周股票复盘：海利生物（603718）将被实施退市风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=2632626920","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632626920?lang=zh_cn&edition=full","pubTime":"2026-05-02 08:14","pubTimestamp":1777680856,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘，海利生物报收于3.9元，较上周的3.96元下跌1.52%。本周，海利生物4月29日盘中最高价报3.98元。本周关注点来自业绩披露要点：海利生物2026年一季报主营收入同比下降23.31%，归母净利润同比下降41.88%。来自公司公告汇总：因净利润为负且营业收入低于3亿元，公司股票将被实施退市风险警示。海利生物关于召开2025年度暨2026年第一季度业绩说明会","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200004070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603718","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631684883","title":"海利生物(603718)3月31日股东户数4.09万户，较上期增加7.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631684883","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631684883?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:31","pubTimestamp":1777541473,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海利生物披露，截至2026年3月31日公司股东户数为4.09万户，较12月31日增加2773.0户，增幅为7.27%。在医疗器械行业个股中，海利生物股东户数高于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.21万户。从股价来看，2025年12月31日至2026年3月31日，海利生物区间跌幅为24.1%，在此期间股东户数增加2773.0户，增幅为7.27%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000056214.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0239","BK0046","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631528154","title":"图解海利生物一季报：第一季度单季净利润同比下降41.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631528154","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631528154?lang=zh_cn&edition=full","pubTime":"2026-04-30 03:16","pubTimestamp":1777490201,"startTime":"0","endTime":"0","summary":"证券之星消息，海利生物2026年一季报显示，一季度公司主营收入4738.87万元，同比下降23.31%；归母净利润633.61万元，同比下降41.88%；扣非净利润448.71万元，同比下降51.22%；负债率25.05%，投资收益9.98万元，财务费用71.2万元，毛利率64.68%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000009124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631516784","title":"海利生物最新公告：5月6日起实施退市风险警示股票简称变更为“*ST海利”","url":"https://stock-news.laohu8.com/highlight/detail?id=2631516784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631516784?lang=zh_cn&edition=full","pubTime":"2026-04-29 20:04","pubTimestamp":1777464244,"startTime":"0","endTime":"0","summary":"海利生物(603718.SH)公告称，公司2025年度经审计的利润总额、净利润及扣非净利润均为负值，且营业收入低于3亿元，触及退市风险警示情形。公司股票将于2026年4月30日停牌一天，自2026年5月6日起实施退市风险警示，股票简称变更为“*ST海利”。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900061150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0239","BK0070","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136477358","title":"海利生物将于4月30日停牌一天 实施退市风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=1136477358","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136477358?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:19","pubTimestamp":1777461555,"startTime":"0","endTime":"0","summary":"海利生物（603718）公告，公司股票将于4月30日停牌一天，并于后续实施退市风险警示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0046","BK0070","603718","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630358098","title":"股市必读：海利生物（603718）预计2025年全年营业收入1.88亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630358098","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630358098?lang=zh_cn&edition=full","pubTime":"2026-04-27 09:58","pubTimestamp":1777255122,"startTime":"0","endTime":"0","summary":"来自公司公告汇总：公司预计2025年扣除非经常性损益后净利润约-62,000万元，营业收入扣除后为18,770万元，低于3亿元，可能触发退市风险警示。业绩披露要点业绩预告海利生物发布业绩预告，预计2025年全年营业收入1.88亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700011714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630807746","title":"每周股票复盘：海利生物（603718）预计2025年营收约1.88亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630807746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630807746?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:32","pubTimestamp":1777156334,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，海利生物报收于3.96元，较上周的4.31元下跌8.12%。本周，海利生物4月20日盘中最高价报4.22元。业绩披露要点海利生物发布业绩预告，预计2025年全年营业收入1.88亿元。经公司财务部门初步测算，预计2025年年度利润总额为-18,740万元左右，归属于母公司所有者的净利润为-31,400万元左右，扣除非经常性损益后的净利润为-62,000万元左右，营业收入为18,780万元左右，扣除后为18,770万元左右，低于3亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600004043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629828692","title":"603359、603718，业绩预告有变，均面临被“*ST”风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2629828692","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629828692?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:31","pubTimestamp":1777041060,"startTime":"0","endTime":"0","summary":" 4月24日盘后，A股市场两家上市公司东珠生态与海利生物相继发布重要公告，对2025年年度业绩预告进行补充或更正。 2025年全年股价涨幅超过72%的东珠生态却在4月24日盘后提示，公司股票可能被实施退市风险警示。此次，东珠生态首次披露扣除后营业收入预计为2.90亿元，低于3亿元的红线。 海利生物董事会在公告中对本次业绩预告更正给投资者带来的影响表达了歉意。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-04-24/doc-inhvrhtu7841900.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-04-24/doc-inhvrhtu7841900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0145","BK0046","603718","BK0070","BK0239","603359","BK0218"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629812907","title":"海利生物最新公告：预计2025年净亏损3.14亿元左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2629812907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629812907?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:44","pubTimestamp":1777023861,"startTime":"0","endTime":"0","summary":"海利生物(603718.SH)发布2025 年年度业绩预告更正公告，预计2025年年度实现归属于母公司所有者的净利润-3.14亿元左右。业绩变动主要系加大商誉减值准备计提比例，以及确认递延所得税负债影响所得税费用，导致利润由盈转亏。注：公司Q4净利润预计亏损0.04亿-亏损0.09亿，Q3净利润0.02亿，据此计算，Q4净利润预计环比由盈转亏。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400053887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0046","603718"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628619793","title":"股市必读：海利生物（603718）4月17日收盘跌5.07%，今年累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628619793","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628619793?lang=zh_cn&edition=full","pubTime":"2026-04-20 02:42","pubTimestamp":1776624129,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，海利生物报收于4.31元，下跌5.07%，换手率4.3%，成交量27.9万手，成交额1.22亿元。交易信息汇总股价提醒4月17日海利生物收盘报4.31元，跌5.07%，当日成交2789.66万元。根据收盘数据统计，该股当年累计跌幅28.17%。前10个交易日资金流向情况：主力资金累计净流出3378.25万元，股价累计下跌7%；融资余额累计增加67.41万元，融券余量累计减少1700股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000001018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","603718","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628357759","title":"每周股票复盘：海利生物（603718）调整瑞盛生物收购价款支付","url":"https://stock-news.laohu8.com/highlight/detail?id=2628357759","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628357759?lang=zh_cn&edition=full","pubTime":"2026-04-19 02:14","pubTimestamp":1776536049,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，海利生物报收于4.31元，较上周的4.54元下跌5.07%。本周关注点来自公司公告汇总：海利生物调整控股子公司瑞盛生物收购常州两家口腔门诊部公司股权的价款支付安排，第二期与第三期合并支付，总金额745万元不变。海利生物关于调整控股子公司收购常州两家口腔连锁公司股权相关价款支付安排的公告显示，本次调整因游金光不承担业绩承诺补偿责任，不影响交易实质，相关股权变更手续尚未办理，交割及整合存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603718","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627296346","title":"海利生物（603718）披露调整控股子公司收购常州两家口腔连锁公司股权相关价款支付安排的公告，4月16日股价上涨1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627296346","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627296346?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:33","pubTimestamp":1776332037,"startTime":"0","endTime":"0","summary":"海利生物于近日披露《关于调整控股子公司收购常州两家口腔连锁公司股权相关价款支付安排的公告》。公告显示，公司于2026年4月15日召开第五届董事会第十九次会议，审议通过《关于调整控股子公司收购常州两家口腔连锁公司股权相关价款支付安排的议案》，同意控股子公司瑞盛生物调整对溧阳金铂利和溧城金铂利两家公司小股东游金光的股权转让款支付方式。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600031922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","603718","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627404831","title":"海利生物(603718.SH)拟投资设立二级子公司并受让扬州、常州七家口腔连锁公司股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2627404831","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627404831?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:03","pubTimestamp":1776240217,"startTime":"0","endTime":"0","summary":"上述股权转让完成后，海利口腔将直接持有扬州、常州七家口腔连锁公司合计100%的股权，瑞盛生物、邹春洋、谢守良通过直接持有海利口腔股权的方式间接各自持有扬州、常州七家口腔连锁公司51%、44%、5%的股权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0070","603718","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626912264","title":"每周股票复盘：海利生物（603718）控股子公司收购七家口腔公司股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2626912264","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626912264?lang=zh_cn&edition=full","pubTime":"2026-04-12 01:55","pubTimestamp":1775930113,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘，海利生物报收于4.54元，较上周的4.43元上涨2.48%。公司公告汇总海利生物关于控股子公司收购口腔连锁公司股权的进展公告上海海利生物技术股份有限公司控股子公司陕西瑞盛生物科技有限公司拟以自有资金6,120万元收购扬州、常州七家口腔连锁公司各51%股权。截至2026年4月3日，常州天宁龙洋金铂利口腔门诊部有限公司和扬州金铂利口腔门诊有限公司已完成工商变更登记，其余公司相关手续仍在办理中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0070","603718","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625311749","title":"海利生物（603718）披露控股子公司收购口腔连锁公司股权进展公告，4月7日股价上涨3.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625311749","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625311749?lang=zh_cn&edition=full","pubTime":"2026-04-07 18:12","pubTimestamp":1775556742,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，海利生物报收于4.58元，较前一交易日上涨3.39%，最新总市值为29.86亿元。近日，海利生物发布《关于控股子公司收购口腔连锁公司股权的进展公告》。公告显示，公司控股子公司陕西瑞盛生物科技有限公司拟以自有资金6,120万元收购扬州、常州七家口腔连锁公司各51%股权。截至2026年4月3日，常州天宁龙洋金铂利口腔门诊部有限公司和扬州金铂利口腔门诊有限公司已完成工商变更登记，其余公司相关手续仍在办理中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700025174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603718","BK0239","BK0070","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625193304","title":"海利生物(603718.SH)：瑞盛生物的GORORISE可吸收胶原膜产品获得MOH批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2625193304","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625193304?lang=zh_cn&edition=full","pubTime":"2026-04-07 16:26","pubTimestamp":1775550396,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海利生物 发布公告，公司控股子公司陕西瑞盛生物科技有限公司于2025年12月向印度尼西亚卫生部递交了瑞盛生物GORORISE Resorbable Collagen Membrane 产品的注册申报资料。瑞盛生物于近日收到MOH通知，瑞盛生物的GORORISE可吸收胶原膜产品获得MOH的批准。临床患者牙缺失后，缺牙部位的牙槽骨常因缺乏功能性刺激而发生进行性吸收，进而导致种植牙时面临骨量不足的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["SG9999014039.USD","BK4588","SG9999014021.USD","BK0046","603718","BK4154","BK0070","BK4585","MOH","SG9999014013.SGD","BK4532","SG9999014005.SGD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625261184","title":"每周股票复盘：海利生物（603718）瑞盛生物拟收购七家口腔公司股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2625261184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625261184?lang=zh_cn&edition=full","pubTime":"2026-04-05 03:45","pubTimestamp":1775331913,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，海利生物报收于4.43元，较上周的4.62元下跌4.11%。本周，海利生物3月31日盘中最高价报4.75元。公司公告汇总海利生物关于控股子公司收购口腔连锁公司股权的进展公告上海海利生物技术股份有限公司控股子公司瑞盛生物拟以自有资金6,120万元收购扬州、常州七家口腔连锁公司各51%股权。截至2026年4月1日，常州天宁龙洋金铂利口腔门诊部有限公司已完成工商变更登记，其余公司相关手续仍在办理中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500001121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0046","603718"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779018569927,"stockEarnings":[{"period":"1week","weight":0.0601},{"period":"1month","weight":-0.1359},{"period":"3month","weight":-0.1917},{"period":"6month","weight":-0.4496},{"period":"1year","weight":-0.4327},{"period":"ytd","weight":-0.3639}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海海利生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"40923人(较上一季度增加7.27%)","perCapita":"15858股","listingDate":"2015-05-15","address":"上海市浦东新区中国(上海)自由贸易试验区临港新片区申港大道133号909室","registeredCapital":"65190万元","survey":" 上海海利生物技术股份有限公司的主营业务是体外诊断试剂（IVD）业务板块和口腔组织修复与再生材料业务板块。公司的主要产品是体外诊断试剂、口腔组织修复与再生材料。公司子公司捷门生物被认定为“上海市专精特新中小企业”、“上海市科技小巨人培育企业”，控股子公司瑞盛生物是陕西省瞪羚企业、陕西省“专精特新”中小企业和陕西省工业企业研发机构。","listedPrice":6.81},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"*ST海利(603718)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供*ST海利(603718)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"*ST海利,603718,*ST海利股票,*ST海利股票老虎,*ST海利股票老虎国际,*ST海利行情,*ST海利股票行情,*ST海利股价,*ST海利股市,*ST海利股票价格,*ST海利股票交易,*ST海利股票购买,*ST海利股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"*ST海利(603718)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供*ST海利(603718)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}